Skip to main content

and
  1. Article

    Open Access

    Individualized atomoxetine response and tolerability in children with ADHD receiving different dosage regimens: the need for CYP2D6 genoty** and therapeutic drug monitoring to dance together

    Integrating CYP2D6 genoty** and therapeutic drug monitoring (TDM) is crucial for guiding individualized atomoxetine therapy in children with attention-deficit/hyperactivity disorder (ADHD). The aim of this retr...

    Hong-Li Guo, Dan-Dan Wu, Di Fu, Yue Li, Jie Wang in Translational Psychiatry (2024)

  2. No Access

    Article

    Personalizing atomoxetine dosing in children with ADHD: what can we learn from current supporting evidence

    There is marked heterogeneity in treatment response of atomoxetine in patients with attention deficit/hyperactivity disorder (ADHD), especially for the pediatric population. This review aims to evaluate curren...

    Di Fu, Hong-Li Guo, Ya-Hui Hu, Wei-Rong Fang in European Journal of Clinical Pharmacology (2023)

  3. No Access

    Article

    Proactive therapeutic drug monitoring of vincristine in pediatric and adult cancer patients: current supporting evidence and future efforts

    Vincristine (VCR), an effective antitumor drug, has been utilized in several polytherapy regimens for acute lymphoblastic leukemia, neuroblastoma and rhabdomyosarcoma. However, clinical evidence shows that the...

    Chun-Ying Wu, Guan-Ting Li, Chen-Chao Chu, Hong-Li Guo in Archives of Toxicology (2023)

  4. No Access

    Article

    The lncRNA Malat1 functions as a ceRNA to contribute to berberine-mediated inhibition of HMGB1 by sponging miR-181c-5p in poststroke inflammation

    Long non-coding RNAs (lncRNAs) have been identified as essential mediators in neurological dysfunction. Our previous study shows that berberine (BBR) hampers the nuclear-to-cytosolic translocation of high-mobi...

    Ding-wen Cao, Man-man Liu, Rui Duan, Yi-fu Tao, Jun-shan Zhou in Acta Pharmacologica Sinica (2020)

  5. No Access

    Article

    Berberine attenuates ischemia–reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation

    Inflammatory damage plays an important role in cerebral ischemic pathogenesis and represents a new target for treatment of stroke. Berberine is a natural medicine with multiple beneficial biological activities...

    Jun-rong Zhu, Hai-dan Lu, Chao Guo, Wei-rong Fang in Acta Pharmacologica Sinica (2018)

  6. No Access

    Article

    Immune Cells After Ischemic Stroke Onset: Roles, Migration, and Target Intervention

    Ischemic stroke is one of the leading health issues and the major cause of permanent disability in adults worldwide. Energy depletion and hypoxia occurring after ischemic stroke result in cell death, which act...

    Lu-yao Ao, Yun-Yi Yan, Lin Zhou, Cheng-yuan Li in Journal of Molecular Neuroscience (2018)

  7. No Access

    Article

    Anti-inflammatory effects of Clematis chinensis Osbeck extract(AR-6) may be associated with NF-κB, TNF-α, and COX-2 in collagen-induced arthritis in rat

    The root of Clematis chinensis Osbeck has been used widely in rheumatoid arthritis in Chinese traditional medicine, and AR-6 is a triterpene saponin isolated from it. In this present study, we investigated the in...

    Cheng Peng, Pathirage Kamal Perera, Yun-man Li, Wei-rong Fang in Rheumatology International (2012)

  8. No Access

    Article

    Effect and mechanism of AR-6 in experimental rheumatoid arthritis

    The root of Clematis chinensis Osbeck has been used widely in rheumatoid arthritis in Chinese traditional medicine and AR-6 is a triterpene saponin isolated from it. In this present study, we investigated in vivo...

    Shi-xue Sun, Yun-man Li, Wei-rong Fang, Peng Cheng in Clinical and Experimental Medicine (2010)